141 related articles for article (PubMed ID: 27812140)
1. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
Berhanu R; Schnippel K; Mohr E; Hirasen K; Evans D; Rosen S; Sanne I
PLoS One; 2016; 11(11):e0164974. PubMed ID: 27812140
[TBL] [Abstract][Full Text] [Related]
2. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
[TBL] [Abstract][Full Text] [Related]
3. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
Evans D; Schnippel K; Govathson C; Sineke T; Black A; Long L; Berhanu R; Rosen S
PLoS One; 2017; 12(7):e0181238. PubMed ID: 28746344
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
5. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Diagnostic Accuracy Study of Abbott RealTi
Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
8. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
[TBL] [Abstract][Full Text] [Related]
9. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
[TBL] [Abstract][Full Text] [Related]
11. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
Cox H; Dickson-Hall L; Ndjeka N; Van't Hoog A; Grant A; Cobelens F; Stevens W; Nicol M
PLoS Med; 2017 Feb; 14(2):e1002238. PubMed ID: 28222095
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
13. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
14. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
15. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
[TBL] [Abstract][Full Text] [Related]
16. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
17. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
Raizada N; Khaparde SD; Rao R; Kalra A; Sarin S; Salhotra VS; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Nair SA; Huddart S; Tripathi R; Surya Prakash CH; Saha BK; Denkinger CM; Boehme C
PLoS One; 2018; 13(8):e0202085. PubMed ID: 30161142
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.
Katende B; Esterhuizen TM; Dippenaar A; Warren RM
Sci Rep; 2020 Feb; 10(1):1917. PubMed ID: 32024860
[TBL] [Abstract][Full Text] [Related]
19. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
[TBL] [Abstract][Full Text] [Related]
20. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]